PhD in Imaging and Molecular analysis of Takotsubo syndrome

il y a 1 semaine


Paris, France France Life Imaging Temps plein

Contexte et mission : OVERVIEW We are looking for a candidate for a science thesis in Cardiovascular Imaging and Pharmacology. Our laboratory is interested in the non‑destructive imaging analysis of energy metabolism and vascularization. We have recently introduced a new non‑invasive imaging technique to simultaneously study these two phenomena and their interactions with PETRUS, which, when applied to the exploration of cardiac pathologies, provides in‑depth information on mechanisms and pharmacological targets for treatment. PROJECT Takotsubo syndrome is a stress‑induced cardiomyopathy affecting mostly women. The clinical picture resembles an infarction without coronary artery obstruction; its prevalence is increasing and it exposes patients to fatal recurrences. There is no treatment. We have identified the metabolic pathways involved, making them potential therapeutic targets. LINES of RESEARCH The main axes of this research topic are: (1) to identify and/or confirm therapeutic targets by PETRUS imaging and molecular analysis, notably by Nanostring and mass spectroscopy; and (2) to experimentally treat Takotsubo syndrome with drugs against the identified targets in the case of (a) a single stress and (b) repeated stress. Work on small laboratory animals. Rémunération Application to the PhD scholarship for 3 years: Doctoral School ED 563, deadline May 5, 2022; see http://parcc.inserm.fr/research-teams/team/tavitian/ Compétences requises Willingness to pursue a career in medical research Good organizational skills Relational skills Rigor Autonomy The ability to adapt in an international multidisciplinary team, scientific curiosity and motivation are essential Contact Bertrand TAVITIAN. Phone: +33 1 53 98 80 54 - http://parcc.inserm.fr/research-teams/team/tavitian/ #J-18808-Ljbffr



  • Paris, France France Life Imaging Temps plein

    Overview Type de structure : Background Nonalcoholic steatohepatitis (NASH) represents an increasing health burden and is quickly becoming the main cause of liver cancer. Magnetic resonance imaging (MRI) proposes several attractive markers for the diagnosis of NASH. MR elastography, because of its sensitivity to tissue visco-elasticity, is a valuable tool...


  • Paris, France EURAXESS Ireland Temps plein

    Organisation/Company CNRS Department Laboratoire de physique de l'ENS Research Field Chemistry > Physical chemistry Physics > Chemical physics Physics > Biophysics Researcher Profile First Stage Researcher (R1) Application Deadline 6 Feb 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 2...


  • Paris, France Euraxess Temps plein

    Organisation/Company CNRS Department Institut Langevin Research Field Engineering Physics Technology Researcher Profile Recognised Researcher (R2) Application Deadline 4 Feb 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Apr 2026 Is the job funded through the EU Research Framework...


  • Paris, France Euraxess Temps plein

    Organisation/Company CNRS Department Institut de biologie de l'Ecole Normale Supérieure Research Field Neurosciences Biological sciences Researcher Profile Recognised Researcher (R2) Application Deadline 2 Feb 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Mar 2026 Is the job funded...


  • Paris, France EURAXESS Ireland Temps plein

    U1266 - CENTRE DE PSYCHIATRIE ET NEUROSCIENCES Organisation/Company CNRS Department U1266 - CENTRE DE PSYCHIATRIE ET NEUROSCIENCES Research Field Physics Researcher Profile First Stage Researcher (R1) Application Deadline 9 Feb 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Apr 2026...


  • Paris, Île-de-France The Bel Group Temps plein

    The Bel Group is a major player in the food industry through portions of dairy, fruit and plant-based products, and one of the world leaders in branded cheeses. Its portfolio of differentiated and internationally recognized brands includes The Laughing Cow, Kiri, Babybel, Boursin Nurishh, Pom'Potes and GoGo squeeZ, as well as some 30 local brands. Together,...


  • Paris, Île-de-France CHEManager International Temps plein

    Qubit Pharmaceuticals is a French-American deeptech startup, focusing on discovering novel molecules for complex targets in healthcare and materials science. We leverage proprietary molecular simulation and quantum-physics based modeling technology to develop our own discovery programs that we either co-develop with or license out to pharmaceutical and...


  • Rue du Faubourg Saint-Jacques Paris, France Qubit Pharmaceuticals Temps plein

    Qubit Pharmaceuticals is a French-American deeptech startup, focusing on discovering novel molecules for complex targets in healthcare and materials science. We leverage proprietary molecular simulation and quantum-physics based modeling technology to develop our own discovery programs that we either co-develop with or license out to pharmaceutical and...


  • Paris, Île-de-France Institut Curie Temps plein

    About UsInstitut Curie Research Centeris a major player in the research and fight against cancer. It consists of a Hospital group and a Research Center of more than 1000 employees with a strong international representativeness. The objective of the Research Center is to develop basic research and to use the knowledge produced to improve the diagnosis,...

  • Molecular Modeling Intern

    il y a 2 semaines


    Rue du Faubourg Saint-Jacques Paris, France Qubit Pharmaceuticals Temps plein

    Qubit Pharmaceuticals is a French-American deeptech startup, focusing on discovering novel molecules for complex targets in healthcare and materials science. We leverage proprietary molecular simulation and quantum-physics based modeling technology to develop our own discovery programs that we either co-develop with or license out to pharmaceutical and...